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Abstract: Human milk contains a complex combination of lipids, proteins, carbohydrates, and
minerals, which are essential for infant growth and development. While the lipid portion constitutes
only 5% of the total human milk composition, it accounts for over 50% of the infant’s daily energy
intake. Human milk lipids vary throughout a feed, day, and through different stages of lactation,
resulting in difficulties in sampling standardization and, like blood, human milk is bioactive
containing endogenous lipases, therefore appropriate storage is critical in order to prevent lipolysis.
Suitable sample preparation, often not described in studies, must also be chosen to achieve the aims of
the study. Gas chromatography methods have classically been carried out to investigate the fatty acid
composition of human milk lipids, but with the advancement of other chromatographic techniques,
such as liquid and supercritical fluid chromatography, as well as mass spectrometry, intact lipids can
also be characterized. Despite the known importance, concise and comprehensive analysis of the
human milk lipidome is limited, with gaps existing in all areas of human milk lipidomics, discussed
in this review. With appropriate methodology and instrumentation, further understanding of the
human milk lipidome and the influence it has on infant outcomes can be achieved.
Keywords: human milk; breastfeeding; lactation; lipids; lipidomics; mass spectrometry;
chromatography; NMR spectroscopy
1. Introduction
Human milk (HM) is vital to the infant, providing both immune protection and energy required
for optimal infant growth. Breastfeeding is associated with multiple benefits for both the infant and
the mother, such as decreased risk of asthma, pneumonia, type 1 diabetes, and obesity and decreased
incidence of breast and ovarian cancer, respectively [1–3]. Further, these breastfeeding benefits increase
with the duration of breastfeeding [1,4].
The macronutrient composition of HM consists of approximately 7% carbohydrates, 5% lipids,
0.9% protein, and 0.2% minerals emulsified in an aqueous milk matrix [5]. While the lipid portion
of HM makes up only 5% of mature milk, it contributes to over 50% of the infant’s daily energy
requirement [6]. These lipids are known to be involved in both neural and retinal tissue development
as well as immune system development and defense in the infant [7–9]. Furthermore, the HM lipid
profile impacts early growth in preterm infants [10].
Despite the importance of these lipids, the total lipid content in HM is highly variable, with
large changes occurring throughout the day, between breasts, between women, and throughout the
whole lactation period [11]. Interestingly, the total HM lipid content is not believed to be changed
by maternal diet; however, diet influences the specific fatty acid (FA) composition. One example of
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this is docosahexaenoic acid (DHA)-containing triacylglycerides (TAGs) which have been found to
be in higher concentrations in HM of women with high seafood intake [12,13]. The concentrations of
DHA, docosapentaenoic acid (DPA), and arachidonic acid (AA) are also observed to decrease over the
lactation period and these are the three FAs implicated in infant neural and retinal development [14].
Along with the variability of HM lipids, the complexity of the milk matrix and lipid hydrophobicity
adds to the difficulty of a comprehensive lipidomic analysis. Further, over 40,000 biological lipid
structures have been identified in various biological matrices such as human blood and plant material,
leaving the possibility for thousands of lipids to be identified and deconvoluted in HM [15].
A number of basic analytical techniques have been employed over the years to investigate the
lipid composition of HM; however, with the recent advancement of analytical techniques such as
chromatography coupled with mass spectrometry and nuclear magnetic resonance spectroscopy,
current analysis promises to be more comprehensive. Lipidomics is the research field in which complex
lipidome analyses are carried out to produce a comprehensive and quantitative description of the
lipid species present in a given matrix. While lipidomics is expanding exponentially in biological
research, it is only recently being applied to HM. Lipids can be defined as FAs and their derivatives, or
by their solubility in organic solvents and insolubility in inorganic solvents. Fat-soluble vitamins such
as vitamin D are often included within this definition of lipids, but for the purpose of this review only
standard lipid classes such as FAs, glycerolipids, glycerophospholipids, sphingolipids, sterols, prenols,
which have been identified in HM will be discussed [16–20].
Additionally, this review will investigate the current status of HM lipidomic analysis and the
new emerging techniques, methods, and instruments being used. It will focus on analysis of HM
lipidome composition, rather than simply total lipids, which has commonly been estimated using
creamatocrit or gravimetric methods [21]. With the present-day state of ‘omics’ techniques, the ability
to comprehensively and quantitatively analyse the HM lipidome will allow a greater understanding
of HM lipids. However, in order to make significant advances in HM analysis, quality control and
standardised sampling must be routinely employed. Lipidomics platforms hold great promise to
further elucidate HM lipid composition and the role of lipids with respect to infant health and disease.
2. Sampling
HM lipid content and composition, as mentioned above, is highly variable and constantly
changing to meet the demands of the infant. The total lipid content of HM varies widely between
women, throughout a feed, a day, and lactation, with reported values ranging widely from 11.4 g/L to
61.8 g/L [11,22,23]. While Jensen suggests that maternal age may influence HM lipid content, this has
not been validated [11]. Similarly, diet has previously been suggested to influence lipid content, yet no
studies exist to confirm this. In contrast, the FA composition of the lipids is influenced by maternal diet,
where areas of China with high fish intake have significantly higher HM DHA than other provinces
with lower fish intake, and DHA supplementation of breastfeeding women in Australia also led to an
increase in HM DHA content [24,25]. While different ethnicity is thought to be another contributor to
lipid composition variability, this too is most probably related to maternal diet. Other maternal health
conditions, such as infections or metabolic diseases, have also been noted to reduce the total lipids
in HM [6]. An obvious limitation to sampling protocols is that these studies are dealing with human
participants, a mother feeding her infant, therefore sampling protocols should not negatively impact
or interrupt infant feeding and sleeping patterns. Sampling protocols are non-invasive, involving
expression of milk from the nipple either manually or using a breast pump. Differences between
sampling methods and timing of collection of the sample may also contribute to complexity and
variations within these results, therefore strict collection protocols should be implemented in order to
obtain representative samples for HM studies. Details of the methods used in HM lipidomics studies,
as well as the other methodology and identified lipids of existing studies, are summarised in Table 1.
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2.1. Sampling with Respect to the Feed
Fat content increases as the breast is drained of milk, during a feed, therefore sampling pre-feed
HM will give lower total fat content than mid- or post-feed samples [26]. Studies often do not
take this into account and do not specify when samples are taken, often accepting random samples
from nonspecified time points. Some studies will sample at a single time point with no further
details, prescribed time points or will attempt to investigate feeds more thoroughly by collecting
pre-, mid- and/or post-feed samples [27–31]. One frequently used sampling method to interrogate
the entire feed is to drain the whole breast using a breast pump and then sample from the pumped
milk [20,32,33]. However, as infants rarely drain the whole breast [34,35], this method will remove
more milk from the end of the feed which is higher in fat content leading to an overestimation of the
infant consumption [36].
2.2. Sampling over 24 h
As fat content increases with removal of milk from the breast subsequently the HM lipid content
varies over a 24-h period, increasing from the first to the last feed of the day, higher in the evening
than in the morning [37]. By sampling and test-weighing the infant before and after each feed in a 24-h
period, milk production can be measured in addition to the actual amount of milk lipid ingested by
the infant [38].
2.3. Sampling through Stages of Lactation
In general, the total HM lipid content increases throughout lactation, with Mitoulas et al. showing
that lipids decrease from the first to second month but increase up to month 9 of lactation [26]. However,
the mean amount of fat delivered to the infant remains constant as maternal milk production and
infant intake changes across the months [26]. In order to account for the fat variations at different
lactation stages, prescribed time points for sampling within a study, such as sampling on certain days
(e.g., day 1, 14, and 42 post-partum) or sampling over a period of lactation (e.g., first 22–25 days of
lactation) should be chosen, depending on the research question [13,29]. However, many studies
either collect at different stages of lactation and pool their samples (such as [39]), or fail to mention
when the samples are collected which makes comparison with other studies and understanding the
lipidome difficult.
2.4. Ideal Sampling Routine
Due to these variations of both the total lipid content and lipid composition, lipidomic analysis at
any given time has the potential to be very different. It is important that the aforementioned factors
are all taken into account when sampling HM and that the study is defined in order to control these
influences. This is rarely the case in HM studies, clearly outlined by the missing data in Table 2.
We suggest defining the research question and then determining the appropriate samples in order
to define and standardize sampling to minimize variables and confounding factors. Given that we
know about the lipid variations at any given time, it is important that studies use sampling with
24-h test-weighing of the infant during breastfeeding (and expression) to provide more accurate
interpretation of infant intake to determine the influence of these lipids on infant development [38].
This technique is not yet widely used but would greatly improve interpretation of research studies.
Taking into account the published sampling methods, these are likely to contribute greatly to the large
variation in reported lipids values [40].
Nutrients 2018, 10, 1169 4 of 20
Table 1. Summary of existing human milk (HM) lipidomics studies from 1959 to 2018, including HM sampling, storage, preparation, quality control (in- and
out-of-sample) and instrumentation used (- indicates not reported).
Lipids Identified Sampling Storage Sample Preparation Quality Control Instrumentation Reference
Fatty acids ranging from 10:0 to 22:6,
including some unknown at the time
6 hospital participants, mid-feed
samples (for 24 h, pooled); 5 participants
at home, random samples
4 ◦C (prior to
pooling);
−15 ◦C
1 or 2 mL human milk










Fatty acids ranging from 12:0 to 22:6 15 participant random samples (pooled) -











Fatty acids ranging from 6:0 to 26:0 7 participants, sampled on day 20–22(mid-feed) On ice ≤2 h; 20
◦C - In: C17:0Out: - GC–FID
van Beusekom
et al. (1993) [28]
Polyunsaturated fatty acids ranging
from 18:2 to 22:6; total saturated FAs;
total monounsaturated FAs
23 participants 7-day samples from a
single feed at weeks 6, 16, 30 (each
time-point pooled)
−20 ◦C prior to
delivery to laboratory






50 m BPX-70 column
Makrides et al.
(1995) [14]
Fatty acids ranging from 10:0 to 22:6
including cis and trans isomers and
some unknown at the time
198 samples, 3–4 weeks, mid-feed for a
day (pooled) -












Fatty acids ranging from 10:0 to 22:6 Samples from 84 participants at day 3and weeks 2, 4, and 6 −20
◦C












Pre- and post-feed samples from 11
participants between days 1–3, days
7–10, days 25–60 (47 samples)





250 mm Spherisorb ODS-2 column
(Solvents: acetonitrile,
dichloromethane, acetone)
Pons et al. (2000)
[42]
Fatty acids ranging from 14:0 to 22:6 34 participants, samples on days 1, 4, 7,14, 21, 28, at any time of day −20
◦C








Fatty acids ranging from 14:0 to 22:6 18 participants, days 1, 2, 3, 4, 5, 6, 7, 14,28 between 0800–1000
4–8 ◦C (for <4 h),
deep freeze, 1
freeze-thaw cycle







40 m Cyanopropyl DB-23 column
Minda et al.
(2004) [44]
1. Fatty acids ranging from 4:0 to
22:6
2. 18:1 t isomers
81 samples, from complete breast
expression, between 0600 and 0800 in
the first month
Room temperature (4
h); Lipid layer frozen
at
−20 ◦C











Groups of FAMES and
approximately 36 × specific FAMEs 1 random sample −20
◦C





In: 14:0 and 17:0
Out: -
GC–EI–MS,
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Table 1. Cont.
Lipids Identified Sampling Storage Sample Preparation Quality Control Instrumentation Reference
DHA and AA and other fatty acids 52 participants -











Fatty acids from 12:0 to 18:2 101 participant random samples over 3days −80









Total saturated and unsaturated fatty
acids, 18:2 n6, 18:3 n3, 20:4 n6, 22:6 n3
29 mid-feed samples (8–12 weeks
post-partum) between 1200 and 1500 −80
◦C










Free fatty acids between C10 and
C24
23 term and 15 preterm participants/38
post-feed samples during days 0–7 day,
8–21, >21
Frozen










Fatty acids between 4:0 and 22:6 50 participants 4 weeks post-partum,provided one full breast expression −80
◦C 250 µL human milk→Transesterification methanolic-HCl




100m CP-Sil 88 column
(Carrier gas: hydrogen)
Cruz-Hernandez
et al. (2013) [32]
Phospholipid classes 50 participants, pre-, mid-, post-feedsamples at 4 weeks −80
◦C












Polar and lipidic metabolites
Tentative 287 lipids (positive mode),
126 lipids (negative mode)
52 samples between days 1 and 76,
pooled. 10 participant samples at week
1, 9 participant samples at week 4
−80 ◦C (long term)
−20 ◦C (short term)








30 m 122-5332G DVB5-MS column
(Carrier gas: helium)
LC–QTOF–MS (ESI)




1. Fatty acids between 10:0 and 20:4
2. Triglycerides between 32:0 and
54:5
2 samples 4 random weeks post-partum -
200 µL human milk
→LLE (1) chloroform:methanol (2:1)
→Transesterification with acid












60 m TRFRAME column
(Carrier gas: helium)




Over 40 triglycerides 15 between-feed samples over days 1–5,6–15 and >16






150 mm Kinetex C18 column
(Solvents: acetonitrile/n-pentanol)
Ten-Domenech
et al. (2015) [53]
Fatty acids ranging from 10:0 to 22:6 477 participants gave pre-feed sampleson days 1, 14, 42 between 1000 and 1100
−20 ◦C;
−80 ◦C
200 µL human milk
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Table 1. Cont.
Lipids Identified Sampling Storage Sample Preparation Quality Control Instrumentation Reference
8 long-chain polyunsaturated fatty
acids
514 participants, between 0900 and 1100
for first 22–25 days −80
◦C
0.2 mL human milk fat
→Transesterification
methanolic-CH3COCl
In: C17:0 Daturic acid
Out: -
GC–FID
100 mm SP2560 column
(Carrier gas: nitrogen)
Liu et al. (2016)
[54]
1. Identified putative DHA-TAGs
2. Verified 56 DHA-TAGs ranging
from C45H74O6 to C67H116O6
1 sample - 0.2 mL human milk→LLE chloroform:methanol (2:1)
In: -
Out: -
1. LC–ESI–triple quadrupole MS
250 mm synergi polar RP column
2. LC–ESI–LTQ–ORBI MS 2x 150
mm Poroshell 120 EC-C18
(Solvents: acetonitrile/water)
Liu et al. (2016)
[29]
Polyunsaturated fatty acids
225 participants, provided pre- and/or
post-feed milk at their own discretion, at
2 months













50 mm SB-C18 column






37 mothers provided 15 (morning and
evening) samples on days 9, 12, 24, 31,
60, 85, 86, 87
−20 ◦C (2–8 days);
−80 ◦C




Wu et al. (2016)
[56]
64 Triglycerides ranging from
C33H62O6 to C65H120O6
27 participants provided a day 7 and
day 42 sample −20
◦C
0.1 mL human milk
→LLE hexane













Tu et al. (2017)
[57]
Fatty acids ranging from 8:0 to 20:3 26 participants, left and a right sample atthe same time on 3 consecutive days
−20 ◦C (≤1 week);
−80 ◦C










1. Fatty acids ranging from 8:0 to
22:6






2 × Phosphatidylserine; Retinol;
9 × Diglycerides; 49×Triglycerideas;
11 × Sphingomyeline;
10 × Eicosanoids; 2×Cardiolipines;
10 × LysoPhosphatidylcholine/
Phosphatidylethanolamine
118 participants gave samples over 24 h
(each participant pooled). −80
◦C








30 m fused silica column
2. LC-ESI-HRMS in positive and
negative mode




et al. (2018) [10]
Abbreviations: LLE liquid-liquid extraction, GC gas chromatography, FID flame ionization detector, TLC thin-layer chromatography, BHT butyrated hydroxytoluene, LC liquid
chromatography, LSD light scattering detector, MS mass spectrometry, EI electron ionization, FAME fatty acid methyl ester, SPE solid phase extraction, DHA docosahexaenoic acid, AA
arachidonic acid, TAG triacylglyceride, NP normal phase, HPLC high pressure liquid chromatography, ELSD evaporative light scattering detector, NMR nuclear magnetic resonance
spectroscopy, MTBE methyl-tert-butyl ether, Q quadrupole, ESI electrospray ionization, APCI atmospheric-pressure chemical ionization, TOF time of flight, LTQ linear trap quadrupole,
ORBI orbitrap, SPME solid-phase microextraction, SFC supercritical fluid chromatography, HRMS high resolution mass spectrometry
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Table 2. Summary of study sampling methods and corresponding total fat content in lactating women. All studies collected pre- and post-feed samples during a 24-h
period. Studies that drained entire breast for samples were excluded. Total fat reported as a range, Mean, (SD or SE) where provided (- indicates not reported or taken
into account).
Sampling DuringFeed Time of Day Lactation Stage






















































31.4 (SD 6.6) - -
20.7–45.7

















- - - - - - - -
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3. Storage
As with lipidomic analysis of all biological samples, care must be taken to minimise lipolysis and
lipogenesis during storage due to enzymes, such as lipase (bile salt-stimulated lipase and lipoprotein
lipase), which are present endogenously in HM [58,59]. While immediate analysis of the lipidome is
ideal to minimize any compositional changes by lipase activity, in reality this is not practical, therefore
correct storage and sample preservation is imperative. Poor consideration of adequate storage affects
the reproducibility and interpretation of HM study results and, as shown in Table 1, is something
rarely considered in HM lipidomics.
3.1. Freezing
Maintaining the integrity of a HM sample is carried out by freezing samples at temperatures such
as −20 ◦C, −70 ◦C or −80 ◦C. If the sample is not frozen adequately, endogenous lipases have the
opportunity to cause lipid hydrolysis resulting in inaccurate and misrepresentative HM lipid content
for measurement. Studies have shown that while freezing HM at −20 ◦C for 3 months resulted in a
significant loss of lipids (up to 20%), storage at −70 ◦C or −80 ◦C stops enzyme activity within the
samples and HM lipid integrity is best preserved [60–62]. Although one study showed major lipid loss
in HM samples stored at −80 ◦C, Fusch et al. reported that this is likely an effect of poor experimental
controls [63,64]. The duration of storage is not routinely reported in published studies but is obviously
another factor affecting results. Another key factor is the number of freeze-thaw cycles that the sample
underwent prior to analysis. In a study by Bitman et al., up to 20% fat loss was observed when HM
underwent two freeze-thaw cycles, due to the resulting increase in lipolytic activity in HM during each
of these cycles [65]. Therefore, steps during sample handling should be carefully planned such that all
samples undergo the same number of freeze-thaw cycles.
3.2. Preservatives
HM has inherent antioxidant capacity to reduce and prevent oxidative degradation [66].
This degradation most commonly occurs in unsaturated fats, where the double bonds undergo cleavage
by free radicals. In addition to freezing HM samples, antioxidant preservation of HM samples has also
been used to maintain sample integrity. Phenol derivatives such as butyrated hydroxytoluene (BHT)
have been used in previous studies to prevent lipid peroxidation [13,67]. BHT works by preferentially
reacting with any oxygen present so that there is no opportunity for the lipids to be oxidatively
degraded. There are currently no HM studies examining BHT efficacy for lipid preservation; however,
studies of other biological samples such as red blood cells have used BHT with success, resulting in
increased red blood cell FA preservation from 4 weeks to at least 17 weeks [68].
4. Lipid Extraction
Following appropriate HM sampling and storage for lipid analysis, sample preparation is essential
to ensure accuracy and reproducibility of the results. For lipidomics analysis, mass spectrometry
techniques, which will be discussed in Section 7.2, are commonly used. Therefore, clean-up steps
such as liquid–liquid extraction and/or solid-phase extraction are essential to remove interferences
such as proteins and sugars, as well as concentrate the lipids of interest. Sample preparation methods
used in HM lipidomics studies are described in Table 1. Prior to lipid extraction, the sample must be
homogenised, to ensure a uniform distribution of milk fat globules throughout the sample.
4.1. Liquid-Liquid Extraction
Liquid-liquid extraction (LLE) techniques are used to separate analyses by their relative solubility
in different immiscible liquids. LLE is the classical choice of lipid extraction method used in HM
analysis, with variations of the 1950s methods such as Folch [14,69] and Bligh–Dyer [70], using
chloroform, methanol, and water in ratios 8:4:3 and 1:2:0.8 respectively, being most commonly used.
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Other than the solvent ratio, the difference in these methods is that Bligh–Dyer uses smaller volumes of
solvent and is a less time-consuming protocol [70]. While the Bligh–Dyer extraction was first developed
on fish muscle, Folch extraction was developed on brain tissue, however both quoted as being easily
adapted to other tissue types. When these solvents are added to HM, the lipids are dissolved into the
organic phase (chloroform) and are separated from the aqueous phase (methanol and water, containing
carbohydrates and salts) by a layer of cell debris and protein (Figure 1i).
While the use of these methods is well established, the drawbacks include the use of hazardous
solvent, such as chloroform, and also the risk of contaminating or losing the lipid-containing lower
phase when sampling through the aqueous phase or separating layers. These methods have been
directly translated into HM studies or modified to either replace the use of hazardous solvent,
such as chloroform with dichloromethane; or increase extraction efficiency with the introduction
of centrifugation to enhance phase separation and the omission of water [27,29]. Recently a
methyl-tert-butyl ether (MTBE) extraction method, initially developed for plasma lipid extraction,
has been employed for HM lipid extraction for the analysis of both lipids and other HM metabolites [51].
This extraction, similar to the Folch and Bligh and Dyer method, separates lipids using phase separation.
However, using the MTBE method, the organic phase containing lipids instead forms the upper layer,
and the aqueous phase (containing the matrix pallet) forms the lower layer (Figure 1ii). This method
has made extraction of lipids simpler and minimizes the potential of cross contamination.
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sphingolipids, prenol lipids and sterol lipids for analysis [46,55]. The first study by Dreiucker and 
Vetter uses a silver-ion SPE to extract FAs separating them by their degree of saturation and isomeric 
configuration [46]. The FAs were then eluted with acetone-based solvents, which then allowed better 
measurement of preseparated FA isomers by GC–MS than in standard LLE extraction. While this 
silver-ion SPE method is more quantitative, it has limitations with reproducibility and 
standardization to ensure complete lipid extraction. In another study, a solid-phase micro extraction 
(SPME) technique was used. This SPME involves the immersion of a solid-phase sorbent-coated fiber 
into HM and then use of organic solvent (such as isopropanol) to desorb the lipids [55]. This technique 
has poor reproducibility for the amount and type of lipids absorbed by the fiber, even when other 
parameters such as time and elution solvent are standardized, thus rendering this method suitable 
Figure 1. Liquid–liquid extraction of human milk lipids using (i) Folch extraction or
(ii) Methyl-tert-butyl ether (MTBE) extraction.
4.2. Solid-Phase Extraction
The use of solid-phase extraction (SPE), a type of colu n chro atography, is gaining popularity
for its rapid and efficient lipid extraction from biological fluids. In this process, HM is loaded
into the cartridge with lipid analyses retained on the solid-phase sorbent, such as C18, packed in
a cartridge, meanwhile the interfering milk matrix components are washed out. Lipids can then
be eluted from the bonded phase using organic solvents (Figure 2) [71]. Only two published milk
lipidome studies have successfully used SPE for lipid extraction from HM, extracting fatty acyls,
glycolipids, sphingolipids, prenol lipids and sterol lipids for analysis [46,55]. The first study by
Dreiucker and Vetter uses a silver-ion SPE to extract FAs separating them by their degree of saturation
and isomeric configuration [46]. The FAs were then eluted with acetone-based solvents, which then
allowed better measurement of preseparated FA isomers by GC–MS than in standard LLE extraction.
While this silver-ion SPE method is more quantitative, it has limitations with reproducibility and
standardization to ensure co plete lipid extraction. In another study, a solid-phase icro extraction
(SP E) technique as used. This SP E involves the i ersion of a solid-phase sorbent-coated fiber
into and then use of organic solvent (such as isopropanol) to desorb the lipids [55]. This technique
has poor reproducibility for the a ount and type of lipids absorbed by the fiber, even hen other
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parameters such as time and elution solvent are standardized, thus rendering this method suitable for
qualitative analyses only. These factors limit the current use of SPE in HM lipidomics; however, further
optimisation could offer the possibility of SPE automation in a plate format, which would make this
technique ideal for routine, high-throughput extraction of HM for lipidomics.
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5. Lipid Transesterification
Following lipid extraction from HM samples, lipid transformation may be required for the analysis
of non-volatile free or lipid-bound FAs. It is generally accepted that free FA in HM are artefacts of
lipolysis, although only one study has investigated the FA from lipase hydrolysis of TAGs and other
lipids (such as phospholipids and sphingolipids) [72]. This section will discuss only the analysis of
FA that make up lipids, more specifically the FA composition of TAGs, which make up 98% of the
lipids in HM, despite the methodology being poorly described (Table 1) [73]. Prior to the analysis of
these FA, a two-part chemical transesterification is carried out, first hydrolysing the TAG, releasing
three FA (Figure 3i), followed by derivatisation of the resulting FA to methyl esters (FAMEs) for GC
analysis (Figure 3ii). This reaction can be either acid or base catalyzed. Derivatisation of FA is necessary
for GC analysis as the high polarity of nonderivatised FA can result in hydrogen bond formation
and therefore adsorption issues on a GC column, leading to band broadening and retention time
shifting [74]. The resulting FAMEs have reduced polarity, able to be separated by a polar GC column.
The transesterification method is well-established and has been widely applied in FA analysis,
where acidic transesterification using boron trifluoride (BF3) is most commonly used, as first
described in 1964 [75]. The early HM FA transesterification methods frequently use this BF3
and methanol approach [10,12,13,43,48]. In other HM studies, transesterifications have used acid
catalysis (methanolic-hydrogen chloride) or base catalysis (using methanolic-potassium hydroxide
or sodium-methoxide) [19,32,45,72]. Although BF3 is a hazardous chemical and could also interact
with BHT preservatives in a sample, it is still widely used in HM preparation [32,76]. The primary
drawbacks of transesterification for FAME analysis are the laborious and time-consuming steps
involved, supporting the movement towards methods not involving such preparations (such as liquid
chromatography–mass spectrometry).
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in human milk. (i) Triglyceride hydrolysis, carried out with a base (such as KOH), resulting in glycerol
and three free fatty acids; (ii) Resulting free fatty acid reaction with methanol and an acid/base catalyst
producing three fatty acid methyl esters and water.
6. Quality Control
The use of quality control (QC) is essential to minimize influences, such as sample matrix
effects and instrument variations that could cause issues with method accuracy and reproducibility.
Despite the importance of QC in lipidomics, it is often overlooked in almost all, not just in HM, studies
(as can be seen in Table 1). The QC measures are generally determined by several factors including
the target lipid class of the study, the availability and cost of the standards and researcher preference.
Several types of QC, which we have categorized as ‘in-sample’ and ‘out-of-sample’ QCs, should also
be in place when lipidomic analyses are carried out and these are described below.
6.1. In Sample
This QC is added in known concentrations to HM during sample preparation and is also referred
to as the internal standard (IS). For optimal lipidomics, more than one compound should be used
as an IS. If these IS are added to HM prior to extraction, they can be used to assess variability that
may occur in sample storage and extraction recovery. If the IS is added after sample extraction, it is
used to monitor instrument performance and variability. The compound selected as an IS should be a
labelled compound that is, or behaves as, the compound/s of interest. Due to limited availability of
expensive commercial labelled lipid standards, to date no HM lipidomics studies have used labelled
lipid standards. HM studies have, however, used a variety of unlabelled commercial lipids which are
presumed not to be present in HM as an IS, for example heptadecanoic acid (C17:0) [28].
6.2. Out of Sample
QC samples should also be analyzed periodically within an experiment to monitor for any
instrument abnormalities, such as sample degradation or loss of response. QCs are typically a pooled
QC or commercial QC. A pooled QC is prepared by pooling aliquots of HM samples from the laboratory
and analyzing these alongside a batch of samples. These QCs need to be rigorously prepared and stored
in order to achieve reproducibility and for accurate monitoring of intra- and inter-batch variations.
The pooled QC is the simplest and cheapest to prepare. Commercial QCs are known lipid analytes
purchased to be run within a batch, like other out-of-sample QCs, confirming and identifying the
retention time, m/z values and identity of these analyses. Additionally, these are often used to test
an instrument for suitability. Out-of-sample QC should always be matrix matched to account for
biological matrix effects, a condition that no HM lipidomic studies have yet met [77].
While there is currently no general consensus on the type of QC that should be used and the
limits of variability within a lipidomics experiment, many studies will predefine the limits based on
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experience and the instruments used. Because of the vast number of lipids, untargeted HM lipidomics
can only ever be semiquantitative [77].
7. Analytical Instrumentation for Lipidomic Analysis
Due to the complexity of lipids, complete lipidomic analysis requires more than one instrument
platform. The choice of instrumentation for HM lipidomics therefore depends upon the study aims and
the lipids of interest. Simple separation techniques have previously been used for qualitative analysis
of lipids, such as thin-layer chromatography and gas chromatography (GC). Although GC is thought
of as the gold standard for HM FA lipidomics, the availability and increasing prevalence of other
separation techniques such as liquid chromatography (LC) and high-resolution mass analyzers, such as
time-of-flight and Fourier Transform, means that the HM lipidome can be more comprehensively
characterized [78]. The advantages and disadvantages of the instrumentation used in HM lipidomic
analysis are summarized in Table 3. Consistent GC use in HM lipidomics can be seen in Table 1,
with the slow emergence of mass spectrometry in recent years.
Table 3. Advantages and disadvantages of analytical instrumentation used in human milk lipidomics.
Separation/Detection Method Advantages Disadvantages
Gas chromatography
1. Fatty acid methyl ester analysis is well
characterized
2. Flame ionisation detector is robust and easy to
maintain
1. Sample derivatisation is required
2. Destructive
3. Isomers separation requires longer column
and run time
4. Flame ionisation detector lacks mass
selectivity
Liquid chromatography 1. No sample derivatisation required2. Large selection of column chemistry available




1. No derivatisation required
2. Compatible with almost any detector type
3. Relatively inexpensive
4. Low waste output
5. Faster separation than in GC/LC
6. Higher resolution than in GC/LC
1. Polar lipid separation requires organic
modifier
Thin-layer chromatography 1. Inexpensive
1. Qualitative lipid class separation only
2. Low separating resolution compared to GC
and LC.
Mass spectrometry 1. High sensitivity and specificity2. Qualitative and quantitative (with standards)
1. Expensive
2. Destructive
NMR spectroscopy 1. Non-destructive2. Highly reproducible
1. Expensive
2. Signal overlapping in complex samples
3. Lower sensitivity than MS
4. Requires larger samples volume
7.1. Separation Methods
7.1.1. Gas Chromatography
GC coupled with a flame ionization detector (GC–FID) is the most routinely used separation
method for FA analysis since the 1950s and is widely accepted for quantification of FA in many sample
types, including HM [19]. Cyanopropyl-based columns ranging from 30 to 60 m in length are typically
employed for FAME analysis. However, longer columns (up to 100 m) are used if separation of
dietary FAME isomers such as cis C18:1 and trans C18:1 is desired. Therefore, the requirement for
a longer GC column can extend both the method preparation and run time. The FID is generally
used in FAME analysis as it is considerably cheaper to purchase and maintain compared to mass
spectrometry (MS) detectors. Furthermore, the robustness of the FID allows the analysis of large
numbers of samples before the need for any maintenance and does not have the same requirements and
issues as MS (such as ionization source cleaning and ionization issues, as seen in mass spectrometry),
discussed in Section 7.2. Mass Spectrometry [79]. Additionally, HM FAME analysis using GC is well
characterized based on elution order and retention time, either requiring a limited number of standards
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or using Kovats retention index, as described in a HM study by Villasenor et al., for identification by
comparing experimental and established retention indices [51]. Further, retention time locking can add
to method reproducibility. However, GC–FID lacks mass selectivity, unlike MS, so it has been known
to misidentify FAMEs in the presence of co-eluting compounds or contaminants that may be present
in the sample, although this has not been investigated in HM studies [80,81].
7.1.2. Liquid Chromatography
While GC is widely used for FA analysis, LC, with an evaporative light-scattering detector (ELSD),
charged aerosol detector (CAD), electrochemical detector, or coupled to mass spectrometry (MS),
has been used in the analysis of intact lipids, such as TAGs and phospholipids [79]. Currently only one
study has used LC–ELSD in HM lipidomics, to quantify phospholipids, while other LC methodology is
most commonly carried out using mass spectrometry [20,53]. Due to the wide variety of lipids in HM,
various stationary phases and solvent combinations are employed depending on the type of lipids and
separation required. Lipid separation in biofluids, including HM, is most often carried out using a C18
stationary phase column but other silica-based stationary phases, such as C8, have also been used in
HM analysis for separation of all lipid classes and phospholipids, respectively [20,51]. Reversed-phase
LC separates intact lipids and free FA based on their specific FA polarity, degree of saturation and chain
length, while normal-phase LC will separate lipids, such as glycerophospholipids, by their class [82].
In LC analyses, the solvent and stationary phase must be compatible with the detection method, for
example MS, where ratios of organic and inorganic solvents such as acetonitrile, alcohol, and water
are most commonly used. When MS is the chosen detector ammonium salts (formate or acetate)
and formic acid will be added (discussed in Section 7.2. Mass Spectrometry). The main advantage
of LC over GC is that transformation is not required and intact lipids such as triglycerides can be
analyzed [83].
7.1.3. Supercritical Fluid Chromatography
Supercritical fluid chromatography (SFC) is another separation technique similar to LC, which,
instead of using a liquid mobile phase, uses a supercritical fluid, such as carbon dioxide (CO2), as the
mobile phase. Supercritical fluids are formed when dense compressed gas is subjected to a specific
pressure and temperature. CO2 is the most commonly used supercritical solvent and its non-polar
properties make it ideal for separating non-polar lipids like TAGs, shown by Laakso and Manninen in
cow’s milk, to separate TAGs by their molecular size [84]. Although SFC has been widely used in dairy
milk fat research and oil separation, its use in HM is limited to one study where SFC was coupled to
mass spectrometry [57]. Advantages of SFC include no requirement for derivatisation, and the ability
for SFC to be coupled with all detector types, such as FID or MS, as well as its low cost and waste
output relative to LC, using less organic solvents than LC, and allowing faster separation and higher
resolution than LC and GC in metabolomics analyses [85]. These features all make SFC well suited to
the analysis of multiple lipid classes in one sample that have a range of polarities [79].
7.1.4. Thin-Layer Chromatography
Like LC, thin-layer chromatography (TLC) may be qualitatively analytical but is more commonly
used as a preparative step in human studies. HM studies often use TLC for separation of lipids into
their individual classes, for example separation of short- and long-chain FAs prior to analysis [72].
This inexpensive technique is classically carried out using a silica plate and non-polar solvent for lipid
class separation, and the classes can then be collected and analyzed using platforms such as GC or LC.
As TLC does not have the separating resolution of GC or LC, its ability to perform identification is
limited and thus may be the reason why TLC is not frequently used in HM lipidomics.
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7.2. Mass Spectrometry
Mass spectrometry (MS) is the detection technique that identifies ionized compounds based on
their mass-to-charge ratio (m/z). This is a destructive technique in which the sample is destroyed and
cannot be used for future analysis. In HM lipidomics analysis, various types of mass analyzers, such as
quadrupole, triple-quadrupole and time-of-flight, have been employed to identify and quantitate
different lipids [79]. Given the increased sensitivity and specificity of MS in contrast to other detector
types, such as FID and ELSD, it is possible to confirm the identity of known lipids, identify unknown
lipids and to elucidate structural information of lipids using MS.
In order for lipids to be detected by MS, the compound needs to be ionized first using one
of a variety of ionization techniques such as EI (electron ionization), ESI (electrospray ionization),
CI (chemical ionization) or MALDI (matrix assisted laser desorption/ionization), which have been
extensively reviewed [78,82]. These ionization methods can be carried out in either positive (EI, CI,
or ESI) or negative (CI or ESI) mode, producing cations or anions respectively. In HM lipidomics, EI
and ESI methods are commonly used. The EI technique is commonly used in conjunction with GC
separation for FA analysis, where lipids are bombarded with a high-energy electron beam causing
them to be ionized and fragmented in characteristic patterns. This is a hard ionization technique
and generally only the fragment ions are observed [82]. Three HM studies have employed GC–MS
since 2011, identifying and quantifying a large number of FAs as derivatised FAMEs, with MS having
the added advantage of identifying many glycerolipids, glycerophospholipids, sphingolipids, prenol
lipids, and sterol lipids not previously identified using GC–FID [46,50,51]. In contrast to EI–MS,
ESI–MS is widely used in LC for HM lipidomics analysis [10,29,51,55]. This soft ionization technique
involves pushing samples through a capillary with a voltage applied to it, creating a fine aerosol where
ions are formed by desolvation. As ESI is a soft ionization technique, it is able to provide information on
both the molecular ion (intact lipid, such as a triglyceride) as well as additional structural information
by fragmenting the molecular ion, such as the FA composition of a specific triglyceride [82].
Additionally, LC–MS often uses additives such as ammonium formate and formic acid in the
mobile phase as modifiers to promote ammonium adduct formation, these adducts being more stable
than hydrogen adducts and easier to fragment than metal ions, and prevent retention time shifting [83].
The use of both positive and negative ionization mode in ESI–MS covers even more lipids, for example,
identifying FAs using negative mode and phospholipids using positive mode [10].
Shotgun MS, which involves introducing a sample directly into the ion source and carrying out
both positive and negative ionization mode MS, is a common technique for untargeted identification
and structural characterization of lipids having been recently used for HM [52]. While this method is
fast, sensitive and only requires a small amount of sample to be injected, the lack of chromatographic
separation and ion suppression makes interpretation difficult. Ion suppression is a common effect
where the response of a species of interest is suppressed due to endogenous matrix species such
as proteins, or exogenous species such as plasticizers from plastic tubes/tube caps, in the sample
compete for ionization [77]. This can be minimized with efficient lipid extraction during sample
preparation, resulting in a cleaner and purer lipid extract. As lipid mixtures are challenging to
interpret, chromatographic preseparation (GC or LC) is usually employed to further assist in separating
lipids/isomers, providing additional orthogonal data for easier identification and more accurate
quantification compared to the shotgun approach [79]. Additionally, untargeted analysis results in a
large number of compounds to interrogate and often requires very specialized and expensive software.
7.3. Nuclear Magnetic Resonance Spectroscopy
Since the introduction of nuclear magnetic resonance spectroscopy (NMR) to the world
of metabolomics, it has been used frequently in analyses of various biofluids and tissues,
including muscle tissue and milk (such as in cows and camels) [86]. NMR is widely used in
HM metabolomics to measure sugars, amino acids, and nucleotides; however, only one lipid
(sn-glycero-3-phosphocholine), 12 phospholipid classes and a small number of lipid derivatives
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have been identified in HM by NMR [86,87]. NMR uses atomic magnetic properties, detecting every
hydrogen/carbon/phosphorus-containing molecule and has the ability to provide valuable structural
information for the intact lipid, such as structural differences between intact phospholipids [62,79].
In contrast to MS, NMR is a non-destructive technique, samples can be re-analyzed with NMR
or other techniques [88]. However the drawbacks of NMR include signal overlapping, which can
make discrimination of resonances from complex samples difficult, as well as larger sample volume
requirements. While the use of NMR may be limited by its lower sensitivity than MS, NMR is highly
reproducible and simple for a trained user to run [56]. Sample preparation may involve lipid extraction,
such as with Folch extraction method, or simply whole milk may be analyzed. While preparation is
simple, it can be difficult to run large numbers of samples with the same high-throughput capability of
MS methods, unless an autosampler is available. The detected analyses can then be quantitated using
the direct relationship between intensity of resonance and concentration [89].
8. Limitations and Future Perspectives
In addition to lipids being the most variable portion of HM, lipidomic analyses are limited by the
number of samples analyzed, limiting the conclusions and relationships that can be identified in studies.
Further, HM lipidomics would greatly benefit from standardized workflows for sample collection
and preparation, analytical methodology on a wide number of platforms, data acquisition and data
processing. The future of HM lipidomics needs higher lipid coverage on multiple platforms, allowing
development of a HM metabolome/lipidome database similar to that of the Human Metabolome
Database [90].
9. Conclusions
HM lipids are an essential macronutrient for the growth, development, and health of the infant;
therefore, HM lipidomics are essential to provide a deeper understanding of short- and long-term
infant health. The recent advances in instrumentation and methods in lipidomics will result in more
comprehensive HM lipidomic investigations. Chromatography, MS, and NMR methods also offer
potential for further lipid identification, structural elucidation, and investigation in HM. To develop
better knowledge of the lipid changes in HM throughout lactation, more rigorous studies need to be
carried out, employing stringent sampling and storage routines and advanced methodology with strict
quality control. Rigorous protocols in HM investigations will allow more accurate assessment and
investigation of the HM lipidome and the impact these lipids have on the infant.
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